IL-6-STAT3 pathway activation induced cancer-associated fibroblasts (CAFs) to generate microvesicles containing miR-221, which was horizontally transferred to breast cancer non-stem cells, thereby promoting their acquisition of CSC-like phenotypes, particularly in combination with hormone therapy [39]. This evidence concerns the gene STAT3 and cancer.